Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
925 INR | +1,90% | +10,93% | -0,68% |
Attività
Numero di dipendenti: 12 220
Vendite per attività
INR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Financing
100,0
%
| 72 927 | 52,1 % | 90 867 | 100,0 % | +24,60% |
Vendite per regione
INR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
India
100,0
%
| 85 413 | 61,0 % | 90 867 | 100,0 % | +6,39% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Rupen Jhaveri
PSD | President | - | 01/12/21 |
Vivek Valsaraj
PSD | President | 51 | - |
Goel Upma
DFI | Director of Finance/CFO | - | 18/08/22 |
Bipin Singh
CMP | Compliance Officer | 56 | 30/07/19 |
Viral Gandhi
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Director/Board Member | 65 | 01/08/99 | |
Director/Board Member | 43 | 01/04/09 | |
Hitesh Dhaddha
IRC | Investor Relations Contact | - | - |
S. K. Honnesh
LAW | General Counsel | - | - |
Corporate Secretary | 66 | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 39 | 12/05/17 | |
Chairman | 68 | - | |
Director/Board Member | 65 | 01/08/99 | |
Shikha Sharma
BRD | Director/Board Member | 64 | 31/03/22 |
Director/Board Member | 51 | 07/10/21 | |
Kunal Bahl
BRD | Director/Board Member | 40 | 14/10/20 |
Anjali Bansal
BRD | Director/Board Member | 53 | 19/11/20 |
Director/Board Member | 63 | 10/02/22 | |
Rajiv Mehrishi
BRD | Director/Board Member | - | 26/05/22 |
- | - |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 224 680 093 | 114 551 387 ( 50,98 %) | 1 124 051 ( 0,5003 %) | 50,98 % |
Partecipazioni
Nome | Azioni | % | Valorizzazione |
---|---|---|---|
PIRAMAL PHARMA LIMITED 0.82% | 10 834 462 | 0.82% | 16 744 878 $ |
Coordinate società
Piramal Enterprises Ltd.
Piramal Ananta, LBS Marg Agastya Corporate Park
400070, Mumbai
+91 22 3802 3000
http://www.piramal.comSocietà del gruppo
Nome | Categoria e settore |
---|---|
Piramal Fund Management Pvt Ltd.
Piramal Fund Management Pvt Ltd. Investment ManagersFinance Piramal Fund Management Pvt Ltd. (Piramal FM) is the private equity and venture capital subsidiary of Piramal Enterprises Ltd. (BSE: 500302) in India. Led by entrepreneur-turned-professional, Mr. Ramesh Jogani, Piramal FM is backed by extensive team experience and a developer's perspective in selecting projects with an inherent assurance of delivery and successful implementation. Established in 2006, the firm advises over USD 450 Million and has invested across various real estate projects in Mumbai, Chennai, Bangalore, Hyderabad and Pune. Piramal FM is headquartered in Mumbai and provides investors with access to their understanding of Indian real estate and their network of partners. |
Investment Managers
|
PHI Fininvest Pvt Ltd.
PHI Fininvest Pvt Ltd. Financial ConglomeratesFinance PHI Fininvest Pvt Ltd. provides financial intermediation services. The company is headquartered in Mumbai, India. |
Financial Conglomerates
|
Piramal Systems & Technologies Pvt Ltd.
| |
Piramal Finance Pvt Ltd.
Piramal Finance Pvt Ltd. Real Estate DevelopmentFinance Piramal Finance Pvt Ltd. provides financial services to business of real estate. The company is headquartered in Mumbai, India. |
Real Estate Development
|
Convergence Chemicals Pvt Ltd.
Convergence Chemicals Pvt Ltd. Chemicals: SpecialtyProcess Industries Convergence Chemicals Pvt Ltd. develops and manufactures specialty fluorochemicals, primarily starting material . The company was founded in November 2014 and is headquartered in Bharuch, India. |
Chemicals: Specialty
|
Piramal Consumer Products Pvt Ltd.
Piramal Consumer Products Pvt Ltd. Investment ManagersFinance Piramal Consumer Products Pvt Ltd. operates as a consumer product division of Piramal Enterprise's Healthcare. It invests and acquires pharmaceuticals and cosmetic products producer firms. The company was founded on July 18, 2012 and is headquartered in Mumbai, India. |
Investment Managers
|
DRG Analytics & Insights Pvt Ltd.
| |
Pharmaceuticals: Major
| |
Piramal Asset Management Pvt Ltd.
|
Settore
Vendite per attività
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-0,68% | 2,49 Mrd | |
-8,14% | 49,88 Mrd | |
-5,25% | 30,53 Mrd | |
+63,88% | 29,08 Mrd | |
+20,03% | 23,38 Mrd | |
+16,97% | 17,94 Mrd | |
-6,99% | 11,81 Mrd | |
+21,92% | 11,27 Mrd | |
-20,90% | 8,31 Mrd | |
+14,34% | 8,13 Mrd |
- Borsa valori
- Azioni
- Azione PEL
- Società Piramal Enterprises Limited